---
pmid: '20478527'
title: An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene
  fusions in prostate cancer progression.
authors:
- Yu J
- Yu J
- Mani RS
- Cao Q
- Brenner CJ
- Cao X
- Wang X
- Wu L
- Li J
- Hu M
- Gong Y
- Cheng H
- Laxman B
- Vellaichamy A
- Shankar S
- Li Y
- Dhanasekaran SM
- Morey R
- Barrette T
- Lonigro RJ
- Tomlins SA
- Varambally S
- Qin ZS
- Chinnaiyan AM
journal: Cancer Cell
year: '2010'
full_text_available: false
pmcid: PMC2874722
doi: 10.1016/j.ccr.2010.03.018
---

# An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene fusions in prostate cancer progression.
**Authors:** Yu J, Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM
**Journal:** Cancer Cell (2010)
**DOI:** [10.1016/j.ccr.2010.03.018](https://doi.org/10.1016/j.ccr.2010.03.018)
**PMC:** [PMC2874722](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874722/)

## Abstract

1. Cancer Cell. 2010 May 18;17(5):443-54. doi: 10.1016/j.ccr.2010.03.018.

An integrated network of androgen receptor, polycomb, and TMPRSS2-ERG gene 
fusions in prostate cancer progression.

Yu J(1), Yu J, Mani RS, Cao Q, Brenner CJ, Cao X, Wang X, Wu L, Li J, Hu M, Gong 
Y, Cheng H, Laxman B, Vellaichamy A, Shankar S, Li Y, Dhanasekaran SM, Morey R, 
Barrette T, Lonigro RJ, Tomlins SA, Varambally S, Qin ZS, Chinnaiyan AM.

Author information:
(1)Michigan Center for Translational Pathology, Department of Pathology, 
University of Michigan Medical School, Ann Arbor, MI 48109, USA.

Comment in
    Cancer Cell. 2010 May 18;17(5):415-6. doi: 10.1016/j.ccr.2010.04.022.

Chromosomal rearrangements fusing the androgen-regulated gene TMPRSS2 to the 
oncogenic ETS transcription factor ERG occur in approximately 50% of prostate 
cancers, but how the fusion products regulate prostate cancer remains unclear. 
Using chromatin immunoprecipitation coupled with massively parallel sequencing, 
we found that ERG disrupts androgen receptor (AR) signaling by inhibiting AR 
expression, binding to and inhibiting AR activity at gene-specific loci, and 
inducing repressive epigenetic programs via direct activation of the H3K27 
methyltransferase EZH2, a Polycomb group protein. These findings provide a 
working model in which TMPRSS2-ERG plays a critical role in cancer progression 
by disrupting lineage-specific differentiation of the prostate and potentiating 
the EZH2-mediated dedifferentiation program.

(c) 2010 Elsevier Inc. All rights reserved.

DOI: 10.1016/j.ccr.2010.03.018
PMCID: PMC2874722
PMID: 20478527 [Indexed for MEDLINE]
